Home > In process > Efficacy and safety of donanemab in the European eligible population: TRAILBLAZER-ALZ 2 post-hoc analyses. > Access to Fulltext
 
 
Main document file(s):
Similar records

DZNEPUB :: Search :: Submit :: Personalize :: Help
Powered by Invenio v1.1.7 | join2_v2604
Maintained by j2-admin@dzne.de

Impressum | Data Privacy Policy